Free Trial

Inspira Technologies Oxy B.H.N. (IINN) Competitors

Inspira Technologies Oxy B.H.N. logo
$0.78 -0.02 (-2.57%)
As of 10:56 AM Eastern

IINN vs. OSRH, AEMD, DRIO, COCH, TMDIF, NMTC, BDMD, NXL, QTI, and LYRA

Should you be buying Inspira Technologies Oxy B.H.N. stock or one of its competitors? The main competitors of Inspira Technologies Oxy B.H.N. include OSR (OSRH), Aethlon Medical (AEMD), DarioHealth (DRIO), Envoy Medical (COCH), Titan Medical (TMDIF), NeuroOne Medical Technologies (NMTC), Baird Medical Investment (BDMD), Nexalin Technology (NXL), QT Imaging (QTI), and Lyra Therapeutics (LYRA). These companies are all part of the "medical equipment" industry.

Inspira Technologies Oxy B.H.N. vs. Its Competitors

OSR (NASDAQ:OSRH) and Inspira Technologies Oxy B.H.N. (NASDAQ:IINN) are both small-cap manufacturing companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, media sentiment, valuation, institutional ownership, analyst recommendations, community ranking, profitability, risk and earnings.

Inspira Technologies Oxy B.H.N. has a consensus price target of $2.00, suggesting a potential upside of 156.90%. Given Inspira Technologies Oxy B.H.N.'s stronger consensus rating and higher probable upside, analysts clearly believe Inspira Technologies Oxy B.H.N. is more favorable than OSR.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OSR
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Inspira Technologies Oxy B.H.N.
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Inspira Technologies Oxy B.H.N. had 5 more articles in the media than OSR. MarketBeat recorded 6 mentions for Inspira Technologies Oxy B.H.N. and 1 mentions for OSR. OSR's average media sentiment score of 1.87 beat Inspira Technologies Oxy B.H.N.'s score of 0.19 indicating that OSR is being referred to more favorably in the media.

Company Overall Sentiment
OSR Very Positive
Inspira Technologies Oxy B.H.N. Neutral

55.3% of OSR shares are owned by institutional investors. Comparatively, 12.7% of Inspira Technologies Oxy B.H.N. shares are owned by institutional investors. 33.7% of OSR shares are owned by insiders. Comparatively, 29.4% of Inspira Technologies Oxy B.H.N. shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

OSR has a beta of 1.61, indicating that its stock price is 61% more volatile than the S&P 500. Comparatively, Inspira Technologies Oxy B.H.N. has a beta of 2.12, indicating that its stock price is 112% more volatile than the S&P 500.

Inspira Technologies Oxy B.H.N. received 5 more outperform votes than OSR when rated by MarketBeat users.

CompanyUnderperformOutperform
OSRN/AN/A
Inspira Technologies Oxy B.H.N.Outperform Votes
5
100.00%
Underperform Votes
No Votes

OSR has higher earnings, but lower revenue than Inspira Technologies Oxy B.H.N..

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OSR-$148.95K-203.83N/AN/AN/A
Inspira Technologies Oxy B.H.N.N/AN/A-$11.29MN/AN/A

Company Net Margins Return on Equity Return on Assets
OSRN/A N/A N/A
Inspira Technologies Oxy B.H.N. N/A N/A N/A

Summary

Inspira Technologies Oxy B.H.N. beats OSR on 7 of the 10 factors compared between the two stocks.

Get Inspira Technologies Oxy B.H.N. News Delivered to You Automatically

Sign up to receive the latest news and ratings for IINN and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IINN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IINN vs. The Competition

MetricInspira Technologies Oxy B.H.N.Surgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$9.83M$4.39B$5.60B$8.62B
Dividend YieldN/A42.67%5.28%4.18%
P/E RatioN/A28.7427.2320.02
Price / SalesN/A71.04417.65154.33
Price / CashN/A51.0838.2534.64
Price / Book1.735.867.124.70
Net Income-$11.29M$67.63M$3.23B$247.97M
7 Day Performance3.80%0.85%2.74%2.64%
1 Month Performance39.02%15.89%8.94%6.39%
1 Year Performance-61.46%19.04%31.59%13.95%

Inspira Technologies Oxy B.H.N. Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IINN
Inspira Technologies Oxy B.H.N.
2.2584 of 5 stars
$0.78
-2.6%
$2.00
+156.9%
-60.1%$9.83MN/A0.0020News Coverage
Short Interest ↑
OSRH
OSR
N/A$1.67
+15.2%
N/AN/A$32.19M-$148.95K0.00N/AGap Down
AEMD
Aethlon Medical
3.151 of 5 stars
$1.99
-13.5%
$7.00
+251.8%
-54.1%$31.96M$570K-1.2610Short Interest ↓
Gap Down
DRIO
DarioHealth
2.0129 of 5 stars
$0.72
-0.7%
$2.00
+179.6%
-44.6%$31.81M$28.03M-0.76200Positive News
COCH
Envoy Medical
2.3334 of 5 stars
$1.48
-0.7%
$9.25
+525.0%
-41.8%$31.56M$212K-1.0734News Coverage
Short Interest ↑
Gap Down
TMDIF
Titan Medical
N/A$0.26
-3.6%
N/A+550.0%$29.13M$17.63M-0.2050
NMTC
NeuroOne Medical Technologies
2.0692 of 5 stars
$0.58
-1.3%
$1.45
+149.5%
-37.9%$28.95M$5.76M-2.2420Gap Up
BDMD
Baird Medical Investment
N/A$4.15
-11.5%
N/AN/A$27.32M$37.04M0.00N/AGap Down
NXL
Nexalin Technology
2.8582 of 5 stars
$1.26
-1.2%
$5.00
+298.4%
+98.3%$21.56M$131.07K-1.963
QTI
QT Imaging
N/A$0.79
flat
N/A+11.9%$21.44M$4.00M0.00N/AGap Down
LYRA
Lyra Therapeutics
2.9153 of 5 stars
$15.50
-15.9%
$100.00
+545.2%
-12.9%$20.54M$1.19M-10.4050Short Interest ↓
Analyst Revision
Gap Down
High Trading Volume

Related Companies and Tools


This page (NASDAQ:IINN) was last updated on 6/12/2025 by MarketBeat.com Staff
From Our Partners